ducovest

UIMP:F:F-UBS ETF - MSCI USA Socially Responsible UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 198.84

Change

+0.28 (+0.14)%

Market Cap

USD 1.67B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: EUR

Country : Germany

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

 USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

 USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

N/A

 USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

 USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

 USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

N/A

 USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

 USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

 USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

N/A

 USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

 USD 49.95B

ETFs Containing UIMP:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.15% 78% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.15% 77% C+ 70% C-
Trailing 12 Months  
Capital Gain 31.82% 87% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.82% 86% B+ 75% C
Trailing 5 Years  
Capital Gain 95.25% 96% N/A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 95.25% 95% A 72% C
Average Annual (5 Year Horizon)  
Capital Gain 12.71% 93% A 83% B
Dividend Return 12.71% 92% A 78% C+
Total Return N/A 77% C+ 94% A
Risk Return Profile  
Volatility (Standard Deviation) 15.90% 33% F 63% D
Risk Adjusted Return 79.97% 95% A 94% A
Market Capitalization 1.67B 83% B 66% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.